Peregrine Pharmaceuticals Inc. (PPHM) Share Price ($):1.70 Price Change: 0.08 (4.94%)

Volume 4,772,559 Avg Volume 2,606,164
Day's Low $1.64 Day's High $1.73
52-wk Low $0.42 52-wk High $5.50
Dividend $NA Yield NA%
Market Cap 222,120,000 P/E (Forward) NA
Chart for PPHM
Exchange: NASDAQ Industry: Pharmaceuticals & Biotechnology Last Trade: 4:00 PM ET 5/24/2013
Last 10 Quotes: What's This?

    Share Liquidity & Volatility

    Compare
    Beta 0.15
    Liquidity Ratio 1,478
    Float 136,152,000
    Shares Outstanding, Basic 137,111,008
    Shares Outstanding, Diluted 60,886,392
    Float as a % of Shares Out 8.49%

    Key Statistics

    Compare
    TTM as of 1/31/2013 Total* Per Share**
    *Figures in thousands
    **Based on most recent share count
    Revenues $15,233 $0.15
    Income from
    Continuing Operations
    $-42,070 $-0.41
    EBIT $-42,029 $-0.41
    Ebitda $-41,121 $-0.41
    Net Income $-42,119 $-0.42
    Cash Flow from Cont. Ops $-35,878 $-0.35
    Free Cash Flow $-37,432 $-0.37
    Cash NA NA
    Long-Term Debt $0 $0.00
    Book Value $12,508 $0.09
    Enterprise Value $193,118 $1.44
    Market Capitalization $222,120 $1.62

    Profitability & Efficiency

    Compare
    TTM as of 1/31/2013
    Gross Margin 47.10%
    Operating Margin -157.89%
    Net Margin -165.25%
    Return on Common Equity -285.67%
    Return on Invested Capital -261.86%
    Return on Assets -98.88%
    Inventory Turnover 2.09
    Asset Turnover 0.60

    Valuation

    Compare
    P/E (GAAP, TTM as of 1/31/2013) NA
    P/E (Pro Forma, TTM as of 1/31/2013) -3.21
    Forward P/E NA
    PEG NA
    Price-to-Book 5.03
    Price-to-Sales 10.93

    Stock Performance

    Compare Dividends
      YTD 52-Week 3-Year 5-Year
    Share Price 28.79% 202.17% -47.69% -20.93%
    Dividends (Yield) NA (NA)
    Dividend Growth (5 years) NA
    Dividend Payout NA
    Dividend X-Date NA
    • Print Snapshot
    • Stock Compare
    • Receive Stock Alerts
    • Receive News Alerts
    • Glossary
    • RSS
    • Price Check Calculator
    • Annual Reports